Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

The Effect of Feverfew Cultivated in Iran for the Prophylactic Treatment of Migraine: A Randomized Placebo-controlled Clinical Trial

Shahram Rafie 1 , Forough Namjoyan 2 , Alireza Hassanzadeh 1 , Fatemeh Yousefbeyk 3 , Shokouhsadat Hamedi 4 and Fereshteh Golfakhrabadi 2 , *
Authors Information
1 Department of Neurology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Pharmacognosy, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Department of Pharmacognosy, School of Pharmacy, Guilan University of Medical Sciences, Rasht, IR Iran
4 Department of Persian Pharmacy, School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: February 01, 2016, 11 (1); e29275
  • Published Online: November 28, 2015
  • Article Type: Research Article
  • Received: April 22, 2015
  • Revised: August 21, 2015
  • Accepted: August 29, 2015
  • DOI: 10.17795/jjnpp-29275

To Cite: Rafie S, Namjoyan F, Hassanzadeh A, Yousefbeyk F, Hamedi S, et al. The Effect of Feverfew Cultivated in Iran for the Prophylactic Treatment of Migraine: A Randomized Placebo-controlled Clinical Trial, Jundishapur J Nat Pharm Prod. 2016 ; 11(1):e29275. doi: 10.17795/jjnpp-29275.

Abstract
Copyright © 2015, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Fantasia HC. Migraine headache prophylaxis in adolescents. Nurs Womens Health. 2014; 18(5): 420-4[DOI][PubMed]
  • 2. Magis D, Schoenen J. Treatment of migraine: update on new therapies. Curr Opin Neurol. 2011; 24(3): 203-10[DOI][PubMed]
  • 3. Chayasirisobhon S. Efficacy of Pinus radiata bark extract and vitamin C combination product as a prophylactic therapy for recalcitrant migraine and long-term results. Acta Neurol Taiwan. 2013; 22(1): 13-21[PubMed]
  • 4. Prior MJ, Codispoti JR, Fu M. A randomized, placebo-controlled trial of acetaminophen for treatment of migraine headache. Headache. 2010; 50(5): 819-33[DOI][PubMed]
  • 5. D'Amico D, Solari A, Usai S, Santoro P, Bernardoni P, Frediani F, et al. Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study. Cephalalgia. 2006; 26(6): 691-6[DOI][PubMed]
  • 6. Lipton RB, Gobel H, Einhaupl KM, Wilks K, Mauskop A. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology. 2004; 63(12): 2240-4[PubMed]
  • 7. Bradley PR. British Herbal Compendium A Handbook of Scientific Information on Widely Used Plant Drugs. 1992;
  • 8. Ernst E, Pittler MH. The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review. Public Health Nutr. 2000; 3(4A): 509-14[PubMed]
  • 9. Mabey DC, Tedder RS, Hughes AS, Corrah PT, Goodison SJ, O'Connor T, et al. Human retroviral infections in The Gambia: prevalence and clinical features. Br Med J (Clin Res Ed). 1988; 296(6615): 83-6[PubMed]
  • 10. Murphy JJ, Heptinstall S, Mitchell JR. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet. 1988; 2(8604): 189-92[PubMed]
  • 11. Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-von Zepelin HH. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia. 2002; 22(7): 523-32[PubMed]
  • 12. Johnson ES, Kadam NP, Hylands DM, Hylands PJ. Efficacy of feverfew as prophylactic treatment of migraine. Br Med J (Clin Res Ed). 1985; 291(6495): 569-73[PubMed]
  • 13. Rose J. Feverfew in the Treatment of Migraine. Clin nutr insights. 1998; 6: 1-2
  • 14. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia. 1988; 8 Suppl 7: 1-96[PubMed]
  • 15. Stewart WF, Lipton RB, Whyte J, Dowson A, Kolodner K, Liberman JN, et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology. 1999; 53(5): 988-94[PubMed]
  • 16. Pareek A, Suthar M, Rathore GS, Bansal V. Feverfew (Tanacetum parthenium L.): A systematic review. Pharmacogn Rev. 2011; 5(9): 103-10[DOI][PubMed]
  • 17. Awang DV. Fever few: A headache for the consumer. HerbalGram. 1993; 29: 34-5
  • 18. Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom. 2004; 18(19): 2273-81[DOI][PubMed]
  • 19. Bone K, Mills S. Principles and practice of phytotherapy: modern herbal medicine. 2013; : 570
  • 20. Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache. 2004; 44(9): 885-90[DOI][PubMed]
  • 21. Shrivastava R, Pechadre JC, John GW. Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study. Clin Drug Investig. 2006; 26(5): 287-96[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments